ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2047

Synovial Fluid Cytokines /Chemokines and Proteins from the Knees of Symptomatic RA and OA Patients Which Correlate with the Magnitude of the Inflammatory Response As Measured By Synovial Fluid WBC Levels

Richard Meehan1, Eric Hoffman2, Mary Wolf3, Elizabeth Regan4, Prashant Parmar5, Karin Pacheco6, Jim Crooks7 and Vijaya Knight8, 1MEDICINE, National Jewish Health, Denver, CO, 2Medicine/Rheumatology, National Jewish Health, Denver, CO, 3Pathology Department, National Jewish Health, Denver, CO, 4Medicine, National Jewish Health, Denver, CO, 5Internal Medicine, St Joseph Hospital, Denver, CO, 6MEDICINE/ Occupational Medince, National Jewish Health, Denver, CO, 7Biostatistics, National Jewish Health, Denver, CO, 8Pathology, ADX laboratory, National Jewish Health, Denver, CO

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Biomarkers, cytokines, OA, pathogenesis and synovial fluid, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Rheumatoid Arthritis – Etiology and Pathogenesis Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Synovial fluid (SF) provides nutritional support for cartilage and contains numerous catabolic and anabolic cytokines, chemokines and proteins. The precise role of these proteins in joint inflammation and cartilage injury in RA and OA, however, are not well understood. Advances in fluoresce bead based multiplex technology allows the measurement of multiple proteins from volumes < 200 mcL. Easier access to SF can allow investigators to identify patient specific wet biomarkers since most of these key regulatory cytokines in the peripheral blood correlate poorly with those measured simultaneously in the SF.

Methods: We performed 54 knee aspirations from 26 symptomatic RA and 8 primary OA patients using an external pneumatic compression device and ultrasound guidance. SF was transferred into heparin containing tubes with WBC levels counted by hemacytometer, then samples were centrifuged and cryopreserved within 60 minutes. Levels of 54 separate cytokines/chemokines and proteins were quantitated in batches of 20 using Luminex or ELISA assays. A significant correlation between log-transformed cytokine levels and WBC counts was determined by a p < 0.05 using Pearson’s product moment between log 10 concentration of specific cytokines and SF WBC levels whereas between group differences was performed using R and SAS programs.

Results: Demographic and clinical features are presented in Table 1. 92% of the OA samples had SF WBC levels < 300 cells/mm3 as did 31% of RA patients. 93% of this RA cohort were receiving prednisone, DMARD or a biologic; yet all had symptomatic knee pain. There was a significant correlation, p<0.05, between all RA and OA patient’s SF 10 WBC counts and log concentration of IL-1, IL-1ra, IL-6, MMP-3, MMP 8 and MMP-9 levels, but not with the other cytokines, chemokines, and proteins. Table 2 displays those specific SF proteins which were higher in either RA or OA patients whereas 43 cytokine/chemokine/protein levels did not differ statistically between both groups of patients.

Conclusion: Sufficient SF volumes were obtained using pneumatic external compression and US to measure 54 separate cytokines, chemokines and proteins from cryopreserved samples from all RA and OA patients using multiplex assays. There was a significant correlation between SF WBC levels and 6 different cytokines, chemokines and proteins, but not in 43 others; yet some biomarkers were higher in OA than RA SF samples. Despite SF WBC < 300 levels in OA and well controlled RA patients, the pro-inflammatory catabolic SF profile suggests an ongoing risk for continued cartilage injury.


Disclosure: R. Meehan, Arthroventions LLC, State of Colorado Industry Accelerator grant and CASIS/NASA grants have supported this rsearch., 2, 4; E. Hoffman, Arthroventions, Grants from CASIS/NASA, State of Colorado, 2, 4; M. Wolf, None; E. Regan, None; P. Parmar, None; K. Pacheco, None; J. Crooks, None; V. Knight, None.

To cite this abstract in AMA style:

Meehan R, Hoffman E, Wolf M, Regan E, Parmar P, Pacheco K, Crooks J, Knight V. Synovial Fluid Cytokines /Chemokines and Proteins from the Knees of Symptomatic RA and OA Patients Which Correlate with the Magnitude of the Inflammatory Response As Measured By Synovial Fluid WBC Levels [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/synovial-fluid-cytokines-chemokines-and-proteins-from-the-knees-of-symptomatic-ra-and-oa-patients-which-correlate-with-the-magnitude-of-the-inflammatory-response-as-measured-by-synovial-fluid-wbc-lev/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/synovial-fluid-cytokines-chemokines-and-proteins-from-the-knees-of-symptomatic-ra-and-oa-patients-which-correlate-with-the-magnitude-of-the-inflammatory-response-as-measured-by-synovial-fluid-wbc-lev/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology